Edition:
United Kingdom

Mithra Pharmaceuticals Signs Principle Agreement For Estelle Commercialization In Canada With Searchlight Pharma


Thursday, 12 Apr 2018 

April 12 (Reuters) - MITHRA PHARMACEUTICALS SA ::SIGNS PRINCIPLE AGREEMENT FOR ESTELLE COMMERCIALIZATION IN CANADA WITH SEARCHLIGHT PHARMA.TOP LINE RESULTS FOR ESTELLE PHASE 3 TRIALS EXPECTED IN Q3 2018 AND Q1 2019.ELIGIBLE TO RECEIVE UP TO EUR 15 MILLION IN UPFRONT PAYMENTS AND SALES-RELATED REVENUES.TO MANUFACTURE ESTELLE FOR SEARCHLIGHT AND RECEIVE GUARANTEED ANNUAL RECURRING REVENUES.THE ANNUAL RECURRING REVENUES TO BE BASED ON MINIMUM ANNUAL QUANTITIES.AGREEMENT COULD ACHIEVE REVENUES OF AT LEAST EUR 50 MILLION FOR MITHRA.